Rekombinanter BRD4 Antikörper (AA 1312-1362)
Kurzübersicht für Rekombinanter BRD4 Antikörper (AA 1312-1362) (ABIN7454041)
Target
Alle BRD4 Antikörper anzeigenAntikörpertyp
Reaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- AA 1312-1362
-
Verwendungszweck
- Rabbit anti-BRD4 Recombinant Monoclonal Antibody [BL-151-6F11]
-
Immunogen
- between AA 1312 and 1362
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Konzentration
- 1000 μg/mL
-
Buffer
- Borate Buffered Saline (BBS) pH 8.2 with 0.09 % Sodium Azide, BSA-Free
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C
-
Haltbarkeit
- 12 months
-
-
- BRD4 (Bromodomain Containing 4 (BRD4))
-
Andere Bezeichnung
- BRD4
-
Hintergrund
- Background: Bromodomain-containing protein 4 (BRD4) contains 2 bromo-domains. Bromo-domains are found in chromatin-associating proteins and can interact specifically with acetylated lysine. BRD4 is described as a chromatin adaptor and has been shown to bind acetylated chromatin. It was originally identified as MCAP (mitotic chromosome associated protein) due to its association with mitotic chromosomes. BRD4 also associates with several transcription complexes such as the Mediator complexes and P-TEFb complexes and is considered to function as a transcriptional co-factor.
-
Gen-ID
- 23476
-
NCBI Accession
- NP_490597
-
UniProt
- O60885
-
Pathways
- Chromatin Binding, SARS-CoV-2 Protein Interaktom
Target
-